{"nctId":"NCT01099774","briefTitle":"Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension","startDateStruct":{"date":"2010-05-01","type":"ACTUAL"},"conditions":["Glaucoma","Ocular Hypertension"],"count":597,"armGroups":[{"label":"Bimatoprost 0.03% Formulation B Ophthalmic Solution","type":"EXPERIMENTAL","interventionNames":["Drug: Bimatoprost 0.03% Formulation B Ophthalmic Solution"]},{"label":"Bimatoprost 0.03% Ophthalmic Solution","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Bimatoprost 0.03% Ophthalmic Solution"]}],"interventions":[{"name":"Bimatoprost 0.03% Formulation B Ophthalmic Solution","otherNames":[]},{"name":"Bimatoprost 0.03% Ophthalmic Solution","otherNames":["LUMIGANÂ®"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient has ocular hypertension or glaucoma in both eyes\n* Requires IOP-lowering therapy in each eye\n\nExclusion Criteria:\n\n* Active or recurrent eye disease that would interfere with interpretation of study data in either eye\n* History of any eye surgery or laser in either eye within 6 months\n* Required chronic use of other eye medications during the study\n* Anticipated wearing of contact lenses during the study.\n* Intermittent use of oral, intramuscular, or intravenous corticosteroids within 21 days","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Worse Eye Intraocular Pressure (IOP) at Week 12","description":"Change from baseline in worse eye IOP at Week 12 . IOP is a measurement of fluid pressure inside the eye. IOP measurements in the worse eye were evaluated at hours 0, 2, and 8. A negative number change from baseline indicated a reduction in IOP, and a positive number change from baseline indicated an increase in IOP.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.90","spread":"2.364"},{"groupId":"OG001","value":"24.86","spread":"2.161"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.79","spread":"2.992"},{"groupId":"OG001","value":"23.78","spread":"2.753"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.81","spread":"3.168"},{"groupId":"OG001","value":"22.80","spread":"3.301"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.49","spread":"2.900"},{"groupId":"OG001","value":"-7.77","spread":"3.029"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.06","spread":"3.333"},{"groupId":"OG001","value":"-7.11","spread":"3.192"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.93","spread":"3.432"},{"groupId":"OG001","value":"-6.06","spread":"3.602"}]}]}]},{"type":"PRIMARY","title":"Average Eye IOP at Week 12","description":"Average Eye IOP at Week 12 . IOP is a measurement of fluid pressure inside the eye. IOP measurements were evaluated at hours 0, 2, and 8 in both eyes and the average IOP of both eyes at each time point were reported. Baseline data are included for reference only.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.53","spread":"2.196"},{"groupId":"OG001","value":"24.46","spread":"2.019"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.30","spread":"2.848"},{"groupId":"OG001","value":"23.26","spread":"2.613"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"22.31","spread":"2.974"},{"groupId":"OG001","value":"22.29","spread":"3.110"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.25","spread":"2.804"},{"groupId":"OG001","value":"16.96","spread":"2.886"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.51","spread":"2.900"},{"groupId":"OG001","value":"16.55","spread":"2.863"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.64","spread":"2.820"},{"groupId":"OG001","value":"16.59","spread":"2.735"}]}]}]},{"type":"PRIMARY","title":"Average Eye IOP at Week 6","description":"Average Eye IOP at Week 6 . IOP is a measurement of fluid pressure inside the eye. IOP measurements were evaluated at hours 0, 2, and 8 in both eyes and the average IOP of both eyes at each time point were reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.16","spread":"2.967"},{"groupId":"OG001","value":"17.08","spread":"2.957"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.52","spread":"2.855"},{"groupId":"OG001","value":"16.45","spread":"2.766"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.56","spread":"2.838"},{"groupId":"OG001","value":"16.32","spread":"2.702"}]}]}]},{"type":"PRIMARY","title":"Average Eye IOP at Week 2","description":"Average Eye IOP at Week 2 . IOP is a measurement of fluid pressure inside the eye. IOP measurements were evaluated at hours 0, 2, and 8 in both eyes and the average IOP of both eyes at each time point were reported.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"17.40","spread":"2.732"},{"groupId":"OG001","value":"17.14","spread":"2.677"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.68","spread":"2.759"},{"groupId":"OG001","value":"16.43","spread":"2.581"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.61","spread":"2.766"},{"groupId":"OG001","value":"16.39","spread":"2.795"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":301},"commonTop":["Conjunctival Hyperaemia"]}}}